With the incidence of nonalcoholic steatohepatitis (NASH), nonalcoholic fatty liver disease (NAFLD) and Clostridioides difficile infection (CDI) on the rise, early intervention is critical for reduction of morbidity and mortality rates. View our new education series for the latest challenges, trends and solutions for diagnosing and managing these conditions.